Tumor suppressor phosphatase tensin homolog (PTEN) is commonly mutated in cancers, and PTEN loss activates oncogenes that reprogram the tumor microenvironment and lead to the formation of brain metastasis. The gene discussed is PTEN; the disease is cancer.